S
Sutro Biopharma D
D
STRO
0.83080
USD
0.03
(4.23%)
مفتوح الان
حجم التداول
9,418
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
70,430,386
العنوان: Sutro Biopharma
القطاع: Healthcare
الصناعة: Biotechnology
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancerand autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.